secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2022-10-19T23:59:59+00:00
Accession:  0001823239-22-000052
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Trey Martin placed on paid leave after court-ordered noncompete TRO; Carl Hull named interim CEO
--------------------------------------------------------------------------------

- Delaware Court of Chancery issued TRO preventing Martin from working for Maravai; pending preliminary injunction hearing later this year.
- Danaher subsidiaries filed suit alleging Martin breached noncompete agreement from prior employment.
- Carl Hull, former CEO and current Executive Chairman, appointed interim CEO to manage day-to-day operations.
- Martin remains on paid leave with same compensation package pending resolution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323922000052/0001823239-22-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323922000052/mrvi-20221018.htm
  HTML page:      https://secwatch.observer/filing/0001823239-22-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer